292 results
Vietnamese: PATH, Chương trình Tiêm chủng mở rộng Quốc gia
Việt Nam là một trong số các quốc gia thành công triển khai hệ thống thông tin tiêm chủng quốc gia trên toàn quốc và đang tiến tới chuyển đổi báo cáo điện...
PATH, Vietnam National Expanded Program on Immunization (NEPI)
The transition of an EIR system from paper-based to digital has financial implications that come with software design, development, and deployment. There are also recurrent costs of operating the...
MOMENTUM Routine Immunization Transformation and Equity Project
This Findings Report includes an overview of the MOMENTUM Routine Immunization Transformation and Equity project’s global mapping of private sector interventions supporting COVID-19 efforts,...
World Bank
This link provides country feature stories on Covid-19 vaccination,This link provides country feature stories on Covid-19 vaccination
World Health Organization (WHO)
South Sudan COVID-19 INTRA-ACTION REVIEW (IAR) Report 2022
World Health Organization (WHO)
COVID-19 Vaccination IAR (Mini cPIE): Implementation updates and lessons learned​
MMGH Consulting
Analysis of COVID-19 Vaccination Intra Action ReviewReports
World Health Organization (WHO)
This implementation guidance summarizes and builds on current global recommendations and programmatic considerations for establishing and/or strengthening platforms for the vaccination of health...
PATH.
In 2020, Ghana's switched from ROTARIX to ROTAVAC in its routine immunization program in order to save money and cold chain space. An economic analysis of this switch, conducted by PATH, the...
World Health Organization (WHO)
This guide aims to reinforce the central importance of quality vaccination services and to offer renewed direction to the design, delivery and evaluation of quality immunization services to increase...
Médecins Sans Frontières (MSF)
New vaccines are much more expensive than older vaccines. Two of the newest vaccines -- against pneumonia and diarrhoea -- account for more than 70% of the total cost of vaccinating a child. Reasons...
Médecins Sans Frontières (MSF)
There are 17 countries currently receiving support and subsidies from GAVI that are due to lose this support by 2016, a process called "graduation." More countries are entering the graduation process...
(a) Defines Policy Coherence for Health Equity. (b) Explains how health actors can promote policy coherence. (c) Measuring policy coherence. (d) Indicators for policy coherence. (e)Annexes...
World Health Organization (WHO)
This document provides guidance, tools and templates to implement the five stages: (1) developing concept; (2) planning and preparing; (3) conducting the review; (4) synthesizing findings; (5)...
World Health Organization (WHO)
A Reference manual which includes an overview of the survey process, tools, and indicators. An Implementation guide which provides a step-by-step instruction for a SARA survey. SARA is a health...
World Health Organization (WHO)
To be useful, competencies are not developed in a vacuum. The competencies framework links the competencies of the workforce to the objectives of an organization, both for planning and for...
PATH
The total cost of ownership (TCO) tool for cold chain equipment (CCE) is designed to help users understand the costs of purchasing and maintaining CCE over time. The tool allows country-specific...
Anna-Lea Kahn, Mercy Mvundura
¿Cuánto más estamos dispuestos a pagar por una vacuna que pueda utilizarse fuera de la cadena de frío? ¿Merece la pena pagar más por una vacuna calificada como CTC? ¿Cómo y cuándo es la CTC...
Anna-Lea Kahn, Mercy Mvundura
How much more are we willing to pay for a vaccine that can be used outside of the cold chain? Are the trade-offs of paying more for a CTC-qualified vaccine worthwhile? How and when is CTC a good...
Ulla Griffiths, Eric Laurent, Charu Garg, Saurabh Agarwal
NIS.COST is a new approach developed by UNICEF for estimating the costs and budget implications of implementing a five-year National Immunization Strategy. The NIS.COST application should be used...
Charu Garg, Eric Laurent, Saurabh Agarwal, Ulla Griffiths
NIS.COST est une nouvelle approche développée par l'UNICEF pour estimer les coûts et les implications budgétaires de la mise en œuvre d'une Stratégie Nationale de Vaccination sur cinq ans....
Charu Garg, Eric Laurent, Saurabh Agarwal, Ulla Griffiths
NIS.COST es un nuevo enfoque desarrollado por UNICEF para estimar los costes y las implicaciones presupuestarias de la aplicación de una Estrategia Nacional de Inmunización de cinco años. La...
Organisation Mondiale de la Santé (OMS)
Il s'agit d'un outil d'estimation du coût de la vaccination contre la COVID-19 : Cet outil est conçu pour aider les gouvernements, les partenaires et autres parties prenantes à estimer le coût...
Organisation Panaméricaine de la Santé (OPS)
Le présent document a pour objet d’aider les pays de la Région des Amériques à planifier les composantes opérationnelles du programme de vaccination en vue des préparatifs concernant le...
Organisation Mondiale de la Santé (OMS)
Ce document d’orientation a été conçu à l’intention des autorités nationales chargées de gérer le déploiement, la mise en œuvre et le suivi des vaccins contre la COVID-19, ainsi que des...
World Health Organization (WHO)
This document is a tool for WHO country leadership and technical staff to guide Members States in the process of aligning human and financial resources to deliver significant increases in COVID-19...
TechNet-21
This files gathers all answers to the questions asked during Sessions #15 of the 'Costing, Budgeting, Financing and Delivery of COVID-19 Vaccines' webinar series. This session was entitled...
World Health Organization (WHO)
This first webinar in a series will provide an introduction to the new approach and the available guidance. The series will continue with sessions in early 2022 focusing on specific steps in the NIS...
TechNet-21
This files gathers all answers to the questions asked during Sessions #11 of the 'Costing, Budgeting, Financing and Delivery of COVID-19 Vaccines' webinar series. This session was entitled 'COVID-19...
TechNet-21
This files gathers all answers to the questions asked during Sessions #13 of the 'Costing, Budgeting, Financing and Delivery of COVID-19 Vaccines' webinar series. This session was entitled 'Mini-cPIE...
TechNet-21
This files gathers all answers to the questions asked during Sessions #12 of the 'Costing, Budgeting, Financing and Delivery of COVID-19 Vaccines' webinar series. This session was entitled...
TechNet-21
This files gathers all answers to the questions asked during Sessions #09 of the 'Costing, Budgeting, Financing and Delivery of COVID-19 Vaccines' webinar series. This session was entitled...
TechNet-21
This files gathers all answers to the questions asked during Sessions #04 of the 'Costing, Budgeting, Financing and Delivery of COVID-19 Vaccines' webinar series. This session was entitled 'Costing...
TechNet-21
This files gathers all answers to the questions asked during Sessions #08 of the 'Costing, Budgeting, Financing and Delivery of COVID-19 Vaccines' webinar series. This session was entitled...
TechNet-21
This files gathers all answers to the questions asked during Sessions #06 of the 'Costing, Budgeting, Financing and Delivery of COVID-19 Vaccines' webinar series. This session was entitled 'Process...
TechNet-21
This files gathers all answers to the questions asked during Sessions #05 of the 'Costing, Budgeting, Financing and Delivery of COVID-19 Vaccines' webinar series. This session was entitled 'Where...
World Health Organization (WHO)
A situational analysis or desk review is commonly recommended for many activities including EPI Reviews and National Immunization Strategy (NIS) development. The objective of this guidance is to...
TechNet-21
This files gathers all answers to the questions asked during Session #01 of the 'Costing, Budgeting, Financing and Delivery of COVID-19 Vaccines' webinar series. The session was entitled '01: How to...
World Health Organization (WHO)
Guidance on conducting vaccine effectiveness evaluations in the setting of new SARS-CoV-2 variants: Interim guidance, 22 July 2021. Addendum to Evaluation of COVID-19 vaccine effectiveness
PATH
Middle-income countries not eligible for support from Gavi, the Vaccine Alliance, have been slow to introduce rotavirus vaccines, largely due to cost concerns. A PATH analysis shows that, in most...
TechNet-21
The consolidated answers to the questions asked during and after Session #13 of the 'COVID-19 Vaccination: Building Global Capacity' webinar series for National and subnational focal points. The...
Frédéric Debellut, Andrew Clark, Clint Pecenka, Jacqueline Tate, Ranju Baral, Colin Sanderson, Umesh Parashar, Deborah Atherly
Middle-income countries (MICs) that are not eligible for funding from Gavi, the Vaccine Alliance, have been slow to adopt rotavirus vaccines. Few studies have evaluated the cost-effectiveness and...
World Health Organization (WHO)
The CVIC tool provides a structured and comprehensive estimation of incremental operational and selected capital costs of introducing and deploying COVID-19 vaccines, in alignment with the National...
TechNet-21
The consolidated answers to the questions asked during and after Session #11 of the 'COVID-19 Vaccination: Building Global Capacity' webinar series for National and subnational focal points. The...
MoH Tanzania
Tanzania's Roll Out Plan identifies responsible EPI person and technical partner, deliverables, and timeline for main HPV vaccine introduction activities.
World Health Organization (WHO)
The WHO initiative, Market Information for Access to Vaccines (MI4A) produces vaccine-specific market studies, analyzing global demand and supply prospects for individual vaccines. The studies...
World Health Organization (WHO)
The WHO initiative, Market Information for Access to Vaccines (MI4A) produces vaccine-specific market studies, analyzing global demand and supply prospects for individual vaccines. The studies...
World Health Organization (WHO)
In addition to providing the most up-to date understanding of the current and future trajectory of global supply and demand of rabies vaccines for PrEP and PEP,8 this study identifies actions to...
World Health Organization (WHO)
This study provides the most up-to-date understanding of current and future global trends and drivers of HPV supply and demand. It also identifies actions to help address the current and expected...
World Health Organization (WHO)
The WHO initiative, Market Information for Access to Vaccines (MI4A) produces vaccine-specific market studies, analyzing global demand and supply prospects for individual vaccines. The studies...
World Health Organization (WHO)
SARS-CoV-2 has impacted health and immunization systems around the world since early 2020 and is likely to alter vaccine markets for several years. This report, based on country-reported purchase...
Anna-Lea Kahn, Mercy Mvundura
How much more are we willing to pay for a vaccine that can be used outside of the cold chain? Are the trade-offs of paying more for a CTC-qualified vaccine worthwhile? How and when is CTC a good...
World Health Organization (WHO)
This Global Vaccine Market Report provides an annual update to Member States, WHO’s international partners and civil society on the state of global vaccine markets
World Health Organization (WHO)
This Immunization Expenditure Situation Analysis working paper seeks to disseminate common knowledge on immunization expenditure to support policymakers in making evidence-based decisions. Key facts...
PATH, The Access and Delivery Partnership (ADP)
Value-based procurement (VBP) is the practice of evaluating potential new products, services, and solutions to maximize overall value for money (VFM), rather than focusing only on the lowest purchase...
Dose Per Container Partnership
This executive summary details the key findings from the 5-dose MCV research in Zambia: improved coverage, reduced wastage, no cold chain constraints, and healthcare workers were more willing to open...
Dose Per Container Partnership
This case study describes the impact of changing to 5-dose measles containing vaccine in Zambia with improved coverage, lower wastage rate and no cold chain constraints.
BID Initiative
During this webinar, VaxTrac presents on common themes and implementation/scale-up challenges that were identified during the recent BLN Study Visit to Benin conducted between 11th and 16th July...
World Health Organization (WHO)
The WHO initiative, Market Information for Access to Vaccines (MI4A) produces vaccine-specific market studies, analyzing global demand and supply prospects for individual vaccines. The studies...
World Health Organization (WHO)
The WHO initiative, Market Information for Access to Vaccines (MI4A) produces vaccine-specific market studies, analyzing global demand and supply prospects for individual vaccines. The studies...
World Health Organization (WHO)
The WHO vaccine market intelligence database compiles vaccine purchase (product, price and procurement) data as reported by countries via the WHO/UNICEF Joint Reporting Form (JRF) over the period...
World Health Organization (WHO)
This Global Vaccine Market Report provides an annual update to Member States, WHO’s international partners and civil society on the state of global vaccine markets. The report is divided into...
World Health Organization (WHO)
This study provides the most updated understanding of current and future global trends and drivers of supply and demand for HPV vaccine. It also identifies actions to help address the current and...
RAND Corporation
This is a framework for making and justifying decisons for purchased services. The authors of this report discuss recent legislation designed to protect small businesses by ensuring that bundling...
World Health Organization (WHO)
Tool for budgeting of Healthcare Waste Management plans in developing countries
Healthcare Without Harm
Comprehensive overview of everything that is involved in developing a proper budget for a Healthcare Waste Management plan. This includes enumerated steps to take, examples and common formulas in...
World Health Organization (WHO)
The purpose of this field guide is to provide comprehensive information on planning and implementing high-quality Supplementary Immunization Activities (SIAs) for injectable vaccines and highlight...
UNICEF
This guidance forms part of the country support packages and responds to a need in the market for effective organizational design that will enhance supply chain efficiency and effectiveness in the...
Dose Per Container Partnership
To help immunization stakeholders make effective DPC decisions for their country context, the Dose Per Container Partnership (DPCP) has developed generalized information based on the partnership’s...
World Health Organization (WHO)
This page makes available existing guidelines and tools related to immunization financing and targeted at immunization service managers, policy-makers, researchers, international donors and health...
Dose Per Container Partnership
This resource is a culmination of DPCP research results to provide decision makers with evidence that can be generalized to other countries when considering vaccine presentation. Country- and...
World Health Organization (WHO)
The HPV Vaccine Introduction Clearing House is a unique space to find WHO publications, tools and other important resources on the human papillomavirus vaccine. The purpose is to help guide HPV...
Hossain A, Politi C, Mandalia N, Cohen AL
Despite the importance of vaccine-preventable disease (VPD) surveillance, little is known about the costs of monitoring disease. We used Comprehensive Multi-Year Plans for Immunization (cMYPs) -...
BID Initiative
The BID Initiative has taken the most frequently used tools from Tanzania and Zambia and made them generic. They can be reused and modified by countries for planning, operations, and change...
World Health Organization (WHO), UNICEF
This WHO-UNICEF Guidance Note provides guidance to countries on how to develop a continuous immunization supply chain (iSC) improvement plan. Its purpose is to help countries build a case for supply...
World Health Organization (WHO), UNICEF
This module describes how to calculate vaccine volumes and evaluate the cold chain capacity requirements of a vaccine supply chain. This module also provides guidance on how to calculate cold chain...
World Health Organization (WHO), UNICEF
This module of the WHO Vaccine Management Handbook (VMH) is a component of the World Health Organization/United Nations Children’s Fund Effective Vaccine Management (EVM) Initiative. The handbook...
Yu W et al.
OBJECTIVE: To estimate the costs of routine immunization (RI) services in China in 2015, to provide objective data relevant to investment in the Expanded Program on Immunization, and to contribute to...
Gavi, the Vaccine Alliance
The Gavi CCEOP Technology Guide aims to provide you with clear advice on new CCE technologies to help you make purchasing decisions. It is intended for use in health facilities and lower levels of...
KinleyDorji et al.
Background: Due to competing health priorities and limited resources, many low-income countries, even those with a high disease burden, are not able to introduce pneumococcal conjugate vaccines....
Marc Poncin et al.
Objective To describe the implementation and feasibility of an innovative mass vaccination strategy – based on single-dose oral cholera vaccine – to curb a cholera epidemic in a large urban...
Steve Ahuka-Mundeke et al.
BACKGROUND: In 2016, the response to a yellow fever outbreak in Angola and the Democratic Republic of Congo led to a global shortage of yellow fever vaccine. As a result, a fractional dose of the...
Jeff Sedita et al.
Abstract: Despite limitations of glass packaging for vaccines, the industry has been slow to implement alternative formats. Polymer containers may address many of these limitations, such as breakage...
Duijzer et al.
Vaccination is one of the most effective ways to prevent and/or control the outbreak of infectious diseases. This medical intervention also brings about many logistical questions. In the past years,...
IsraelLarena Fernández et al.
Objectives: Cold chain control is one of the most important facts to ensure the effectiveness of vaccines links, which requires specific material and human resources for management. The principal...
TaniaCernuschi et al.
Over the past decade, several countries across all regions, income groups and procurement methods have been unable to secure sufficient BCG vaccine supply. While the frequency of stock-outs has...
Pieter T. de Boer et al.
Background: To inform national healthcare authorities whether quadrivalent influenza vaccines (QIVs) provide better value for money than trivalent influenza vaccines (TIVs), we assessed the...
S. Mokiou et al.
The administration of a vaccine dose involves a series of activities prior to and on the day of vaccine delivery. Total vaccination cost should include the cost of each activity, which is often not...
Ke Xu et al.
This WHO report summarizes the latest internationally comparable data on health spending in all WHO Member States between 2000 and 2015. But it does more than publish the most recent data. For the...
Village Reach
This document summarises the current state of the country’s immunisation supply chain and how additional value and efficiency can be achieved. It specifically examines overall costs, health worker...
Laura Kerr
As the Global Polio Eradication Initiative (GPEI) winds down, the 16 countries that receive 95% of GPEI’s support will face significant challenges from decreased funding over the next three years....
Chandra D & Kumar D
INTRODUCTION: In recent years, demand to improve child immunization coverage globally, and the development of the latest vaccines and technology has made the vaccine market very complex. The rise in...
Songane M
Vaccines are very effective in providing individual and community (herd) immunity against a range of diseases. In addition to protection against a range of diseases, vaccines also have social and...
Africa Health Budget Network (AHBN)
Nigeria over the last few years has been unable to fully fund its immunization needs. This was largely attributed to dwindling national resources, rising cost of vaccine, inadequate yearly budgetary...